DUBLIN, Sept. 20, 2022 /PRNewswire/ — The “Cancer Immunotherapy Global Market Report 2022” report has been added to ResearchAndMarkets.com’s offering.
The global cancer immunotheaphy market is expected to grow from $77.72 billion in 2021 to $85.70 billion in 2022 at a compound annual growth rate (CAGR) of 10.27%. The cancer immunotheraphy market is expected to reach $145.16 billion in 2026 at a CAGR of 14.08%.
North America was the largest region in the cancer immunotherapy market and is also expected to be the fastest-growing region in the forecast period. The regions covered in cancer immunotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The rise in cancer incidence is expected to propel the cancer immunotherapy market. The factors contributing to the growth in cancer cases across the globe include tobacco, alcohol, obesity, a sedentary lifestyle, and environmental factors. This growth in cancer cases is expected to boost demand for cancer immunotherapies, as patients are increasingly investing in medical treatments with greater recovery and minimal pain.
For instance, according to the report published by National Cancer Institute (USA), in 2020, cancer was among the leading causes of death worldwide, with an estimated 1,806,590 new cases and 606,520 deaths due to cancer in the United States.By 2040, the number…